Related Experiment Video
Updated: Jan 23, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Fibulin-3 as biomarker of malignant mesothelioma
Caterina Ledda1, Rosario Caltabiano2, Francesca Vella1
1Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.
Abstract:
Many malignant diseases are associated with past asbestos exposure; the most lethal and strictly related to previous fiber exposure being malignant mesothelioma (MM). Effective preventive protocols may include sensitive and specific biomarkers. The role of Fb-3 has been recently investigated for MM early detection, but its role is still under debate. After an independent search for scientific literature, nine studies were included for a systematic review. Human Fb-3 levels seem to be able to separate healthy people with previous exposure to asbestiform fibers from MM patients. Fb-3 blood levels can distinguish MM effusions from other malignant and benign effusions. Furthers investigations on more significant groups of patients are desirable to validate and assess the validity of combining Fb-3 with other biomarkers.
Insights
Fibulin-3 (Fb-3) shows promise as a biomarker for early detection of malignant mesothelioma (MM) in individuals with asbestos exposure. Fb-3 levels can differentiate MM patients from healthy individuals and distinguish MM effusions from other effusions.
Area of Science:
- Oncology
- Biomarker Discovery
- Environmental Health
Background:
- Asbestos exposure is a significant risk factor for malignant mesothelioma (MM), a lethal cancer.
- Early detection of MM is crucial for effective treatment and improved patient outcomes.
- The identification of sensitive and specific biomarkers is essential for developing preventive protocols.
Purpose of the Study:
- To systematically review the existing literature on the role of Fibulin-3 (Fb-3) as a biomarker for malignant mesothelioma (MM) early detection.
- To evaluate the diagnostic accuracy of Fb-3 in distinguishing MM patients from healthy individuals with asbestos exposure.
- To assess the utility of Fb-3 in differentiating MM-associated effusions from other malignant and benign effusions.
Main Methods:
- A systematic review of nine independent scientific studies.
- Literature search conducted to identify relevant research on Fb-3 and MM.
- Analysis of Fb-3 levels in blood and effusions from MM patients and control groups.
Main Results:
- Human Fb-3 levels demonstrated an ability to differentiate between healthy individuals with prior asbestos exposure and MM patients.
- Fb-3 blood levels were found to be effective in distinguishing malignant mesothelioma effusions from other types of effusions.
- The findings suggest Fb-3's potential as a diagnostic marker for MM.
Conclusions:
- Fibulin-3 (Fb-3) shows potential as a valuable biomarker for the early detection of malignant mesothelioma (MM).
- Fb-3 can help distinguish MM patients from asbestos-exposed healthy individuals and differentiate MM effusions.
- Further large-scale studies are recommended to validate these findings and explore combining Fb-3 with other biomarkers for enhanced diagnostic accuracy.
Related Concept Videos
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Piaget's Stage 3 of Cognitive Development
Conservation and Constancy of Quantity
A significant cognitive milestone in the...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Electron Configuration of Multielectron Atoms
Hybridization of Atomic Orbitals II

